Michael S. Poirier serves as Executive at Qualigen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael S. Poirier has executed 3 insider transactions totaling $36.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 22, 2022 involved purchasing 30,000 shares valued at $17.1K.
Michael S. Poirier currently holds 199,202 shares of Qualigen Therapeutics, Inc. (QLGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael S. Poirier has been a net buyer of QLGN stock. They have purchased $36.9K and sold $0 worth of shares.
Michael S. Poirier's most recent insider trade was on Jun 22, 2022, when they purchased 30,000 shares at $0.57 per share.
Get notified when new Form 4 filings are submitted
| $1.80 |
| Discretionary |
| May 22, 2020 | QLGN | $0 | Other | 169,192 | $N/A | Discretionary |